Patent details

Basic Information

Publication number:

EP1174138

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP011196136

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Use of mometasone furoate for treating airway passage and lung diseases

French Title of Invention:

Utilisation du furoate de mometasone pour le traitement des affections pulmonaires et des voies respiratoires

German Title of Invention:

Verwendung von Mometason-Furoat zur Behandlung von Luftweg- und Lungenerkrankungen

SPC Number:

Dates

Filing date:

26/01/1995

Grant date:

03/08/2011

EP Publication Date:

03/08/2011

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

23/01/2002

EP B1 Publication Date:

03/08/2011

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

26/01/2015

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

19/07/2012

 

 

Name:

Merck Sharp & Dohme Corp.

Address:

126 East Lincoln Avenue, 07065-0907, Rahway NJ, United States (US)

Agent

Name:

MARKS & CLERK LLP

From:

21/09/2011

Address:

BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)

To:

Inventor

1

Name:

Nagabhushan Nagamani

Address:

United States (US)

2

Name:

Cuss Francis M.

Address:

United States (US)

3

Name:

Nolop Keith B.

Address:

United States (US)

4

Name:

Sequeira Joel A.

Address:

United States (US)

5

Name:

Chaudry Imtiaz A.

Address:

United States (US)

6

Name:

Patrick James E.

Address:

United States (US)

7

Name:

Cayen Mitchell

Address:

United States (US)

Priority

Priority Number:

188372

Priority Date:

27/01/1994

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 9/00;

Filing date	Document type	Number of pages
12/08/2022	Request For Change	1
02/09/2022	Outgoing Correspondence	56